Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-25
1997-01-21
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514259, 514269, 514309, 514312, 514314, 544284, 544298, 544315, 544319, 544322, 544328, 546142, 546153, 546155, 546159, A61K 3147, A61K 31505, C07D40112, C07D40312
Patent
active
055960014
ABSTRACT:
Compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, m, X and Q are as defined below, and novel intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and natiatherosclerosis agents.
REFERENCES:
patent: 4623662 (1986-11-01), DeVries
patent: 4716175 (1987-12-01), Hoefle et al.
patent: 4743605 (1988-05-01), Hoefle et al.
patent: 5254565 (1993-10-01), Meguro et al.
Schaefer et al. CA 80: 3361f, p. 294, 1974.
Bekelnitzky Seymour G.
Ginsburg Paul H.
Gupta Yogendra N.
Pfizer Inc.
Richardson Peter C.
LandOfFree
4-aryl-3-(heteroarylureido)quinoline derivatves does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aryl-3-(heteroarylureido)quinoline derivatves, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aryl-3-(heteroarylureido)quinoline derivatves will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324392